Pharma & Healthcare

Global HER2 Antibody Market Research Report 2024

HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is recommended for all patients with HER2-positive breast cancer who are also receiving chemotherapy.
The global HER2 Antibody market was valued at US$ 13980 million in 2023 and is anticipated to reach US$ 23040 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
Monoclonal antibodies targeting HER2 (human epidermal growth factor receptor 2) are used in the treatment of HER2-positive breast cancer. Market trends include the development of next-generation HER2-targeted therapies and combination therapies to enhance treatment efficacy.
This report aims to provide a comprehensive presentation of the global market for HER2 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HER2 Antibody.
Report Scope
The HER2 Antibody market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HER2 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HER2 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Genentech Inc
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Segment by Type
Trastuzumab
Lapatinib
Ado-trastuzumab Emtansine
Pertuzumab
Everolimus
Segment by Application
Hospital
Medical Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HER2 Antibody companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HER2 Antibody Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Trastuzumab
1.2.3 Lapatinib
1.2.4 Ado-trastuzumab Emtansine
1.2.5 Pertuzumab
1.2.6 Everolimus
1.3 Market by Application
1.3.1 Global HER2 Antibody Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Medical Center
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HER2 Antibody Market Perspective (2019-2030)
2.2 HER2 Antibody Growth Trends by Region
2.2.1 Global HER2 Antibody Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 HER2 Antibody Historic Market Size by Region (2019-2024)
2.2.3 HER2 Antibody Forecasted Market Size by Region (2025-2030)
2.3 HER2 Antibody Market Dynamics
2.3.1 HER2 Antibody Industry Trends
2.3.2 HER2 Antibody Market Drivers
2.3.3 HER2 Antibody Market Challenges
2.3.4 HER2 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HER2 Antibody Players by Revenue
3.1.1 Global Top HER2 Antibody Players by Revenue (2019-2024)
3.1.2 Global HER2 Antibody Revenue Market Share by Players (2019-2024)
3.2 Global HER2 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HER2 Antibody Revenue
3.4 Global HER2 Antibody Market Concentration Ratio
3.4.1 Global HER2 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HER2 Antibody Revenue in 2023
3.5 HER2 Antibody Key Players Head office and Area Served
3.6 Key Players HER2 Antibody Product Solution and Service
3.7 Date of Enter into HER2 Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HER2 Antibody Breakdown Data by Type
4.1 Global HER2 Antibody Historic Market Size by Type (2019-2024)
4.2 Global HER2 Antibody Forecasted Market Size by Type (2025-2030)
5 HER2 Antibody Breakdown Data by Application
5.1 Global HER2 Antibody Historic Market Size by Application (2019-2024)
5.2 Global HER2 Antibody Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America HER2 Antibody Market Size (2019-2030)
6.2 North America HER2 Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America HER2 Antibody Market Size by Country (2019-2024)
6.4 North America HER2 Antibody Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HER2 Antibody Market Size (2019-2030)
7.2 Europe HER2 Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe HER2 Antibody Market Size by Country (2019-2024)
7.4 Europe HER2 Antibody Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HER2 Antibody Market Size (2019-2030)
8.2 Asia-Pacific HER2 Antibody Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific HER2 Antibody Market Size by Region (2019-2024)
8.4 Asia-Pacific HER2 Antibody Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HER2 Antibody Market Size (2019-2030)
9.2 Latin America HER2 Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America HER2 Antibody Market Size by Country (2019-2024)
9.4 Latin America HER2 Antibody Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HER2 Antibody Market Size (2019-2030)
10.2 Middle East & Africa HER2 Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa HER2 Antibody Market Size by Country (2019-2024)
10.4 Middle East & Africa HER2 Antibody Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genentech Inc
11.1.1 Genentech Inc Company Detail
11.1.2 Genentech Inc Business Overview
11.1.3 Genentech Inc HER2 Antibody Introduction
11.1.4 Genentech Inc Revenue in HER2 Antibody Business (2019-2024)
11.1.5 Genentech Inc Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Detail
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG HER2 Antibody Introduction
11.2.4 Novartis AG Revenue in HER2 Antibody Business (2019-2024)
11.2.5 Novartis AG Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer HER2 Antibody Introduction
11.3.4 Pfizer Revenue in HER2 Antibody Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Abnova Corporation
11.4.1 Abnova Corporation Company Detail
11.4.2 Abnova Corporation Business Overview
11.4.3 Abnova Corporation HER2 Antibody Introduction
11.4.4 Abnova Corporation Revenue in HER2 Antibody Business (2019-2024)
11.4.5 Abnova Corporation Recent Development
11.5 InvivoGen
11.5.1 InvivoGen Company Detail
11.5.2 InvivoGen Business Overview
11.5.3 InvivoGen HER2 Antibody Introduction
11.5.4 InvivoGen Revenue in HER2 Antibody Business (2019-2024)
11.5.5 InvivoGen Recent Development
11.6 Celltrion
11.6.1 Celltrion Company Detail
11.6.2 Celltrion Business Overview
11.6.3 Celltrion HER2 Antibody Introduction
11.6.4 Celltrion Revenue in HER2 Antibody Business (2019-2024)
11.6.5 Celltrion Recent Development
11.7 Biocon Limited
11.7.1 Biocon Limited Company Detail
11.7.2 Biocon Limited Business Overview
11.7.3 Biocon Limited HER2 Antibody Introduction
11.7.4 Biocon Limited Revenue in HER2 Antibody Business (2019-2024)
11.7.5 Biocon Limited Recent Development
11.8 Bio-Techne
11.8.1 Bio-Techne Company Detail
11.8.2 Bio-Techne Business Overview
11.8.3 Bio-Techne HER2 Antibody Introduction
11.8.4 Bio-Techne Revenue in HER2 Antibody Business (2019-2024)
11.8.5 Bio-Techne Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global HER2 Antibody Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Trastuzumab
Table 3. Key Players of Lapatinib
Table 4. Key Players of Ado-trastuzumab Emtansine
Table 5. Key Players of Pertuzumab
Table 6. Key Players of Everolimus
Table 7. Global HER2 Antibody Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global HER2 Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global HER2 Antibody Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global HER2 Antibody Market Share by Region (2019-2024)
Table 11. Global HER2 Antibody Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global HER2 Antibody Market Share by Region (2025-2030)
Table 13. HER2 Antibody Market Trends
Table 14. HER2 Antibody Market Drivers
Table 15. HER2 Antibody Market Challenges
Table 16. HER2 Antibody Market Restraints
Table 17. Global HER2 Antibody Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global HER2 Antibody Market Share by Players (2019-2024)
Table 19. Global Top HER2 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Antibody as of 2023)
Table 20. Ranking of Global Top HER2 Antibody Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by HER2 Antibody Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players HER2 Antibody Product Solution and Service
Table 24. Date of Enter into HER2 Antibody Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global HER2 Antibody Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global HER2 Antibody Revenue Market Share by Type (2019-2024)
Table 28. Global HER2 Antibody Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global HER2 Antibody Revenue Market Share by Type (2025-2030)
Table 30. Global HER2 Antibody Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global HER2 Antibody Revenue Market Share by Application (2019-2024)
Table 32. Global HER2 Antibody Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global HER2 Antibody Revenue Market Share by Application (2025-2030)
Table 34. North America HER2 Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America HER2 Antibody Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America HER2 Antibody Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe HER2 Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe HER2 Antibody Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe HER2 Antibody Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific HER2 Antibody Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific HER2 Antibody Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific HER2 Antibody Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America HER2 Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America HER2 Antibody Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America HER2 Antibody Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa HER2 Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa HER2 Antibody Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa HER2 Antibody Market Size by Country (2025-2030) & (US$ Million)
Table 49. Genentech Inc Company Detail
Table 50. Genentech Inc Business Overview
Table 51. Genentech Inc HER2 Antibody Product
Table 52. Genentech Inc Revenue in HER2 Antibody Business (2019-2024) & (US$ Million)
Table 53. Genentech Inc Recent Development
Table 54. Novartis AG Company Detail
Table 55. Novartis AG Business Overview
Table 56. Novartis AG HER2 Antibody Product
Table 57. Novartis AG Revenue in HER2 Antibody Business (2019-2024) & (US$ Million)
Table 58. Novartis AG Recent Development
Table 59. Pfizer Company Detail
Table 60. Pfizer Business Overview
Table 61. Pfizer HER2 Antibody Product
Table 62. Pfizer Revenue in HER2 Antibody Business (2019-2024) & (US$ Million)
Table 63. Pfizer Recent Development
Table 64. Abnova Corporation Company Detail
Table 65. Abnova Corporation Business Overview
Table 66. Abnova Corporation HER2 Antibody Product
Table 67. Abnova Corporation Revenue in HER2 Antibody Business (2019-2024) & (US$ Million)
Table 68. Abnova Corporation Recent Development
Table 69. InvivoGen Company Detail
Table 70. InvivoGen Business Overview
Table 71. InvivoGen HER2 Antibody Product
Table 72. InvivoGen Revenue in HER2 Antibody Business (2019-2024) & (US$ Million)
Table 73. InvivoGen Recent Development
Table 74. Celltrion Company Detail
Table 75. Celltrion Business Overview
Table 76. Celltrion HER2 Antibody Product
Table 77. Celltrion Revenue in HER2 Antibody Business (2019-2024) & (US$ Million)
Table 78. Celltrion Recent Development
Table 79. Biocon Limited Company Detail
Table 80. Biocon Limited Business Overview
Table 81. Biocon Limited HER2 Antibody Product
Table 82. Biocon Limited Revenue in HER2 Antibody Business (2019-2024) & (US$ Million)
Table 83. Biocon Limited Recent Development
Table 84. Bio-Techne Company Detail
Table 85. Bio-Techne Business Overview
Table 86. Bio-Techne HER2 Antibody Product
Table 87. Bio-Techne Revenue in HER2 Antibody Business (2019-2024) & (US$ Million)
Table 88. Bio-Techne Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HER2 Antibody Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global HER2 Antibody Market Share by Type: 2023 VS 2030
Figure 3. Trastuzumab Features
Figure 4. Lapatinib Features
Figure 5. Ado-trastuzumab Emtansine Features
Figure 6. Pertuzumab Features
Figure 7. Everolimus Features
Figure 8. Global HER2 Antibody Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global HER2 Antibody Market Share by Application: 2023 VS 2030
Figure 10. Hospital Case Studies
Figure 11. Medical Center Case Studies
Figure 12. HER2 Antibody Report Years Considered
Figure 13. Global HER2 Antibody Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global HER2 Antibody Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global HER2 Antibody Market Share by Region: 2023 VS 2030
Figure 16. Global HER2 Antibody Market Share by Players in 2023
Figure 17. Global Top HER2 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Antibody as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by HER2 Antibody Revenue in 2023
Figure 19. North America HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America HER2 Antibody Market Share by Country (2019-2030)
Figure 21. United States HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe HER2 Antibody Market Share by Country (2019-2030)
Figure 25. Germany HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific HER2 Antibody Market Share by Region (2019-2030)
Figure 33. China HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America HER2 Antibody Market Share by Country (2019-2030)
Figure 41. Mexico HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa HER2 Antibody Market Share by Country (2019-2030)
Figure 45. Turkey HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia HER2 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Genentech Inc Revenue Growth Rate in HER2 Antibody Business (2019-2024)
Figure 48. Novartis AG Revenue Growth Rate in HER2 Antibody Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in HER2 Antibody Business (2019-2024)
Figure 50. Abnova Corporation Revenue Growth Rate in HER2 Antibody Business (2019-2024)
Figure 51. InvivoGen Revenue Growth Rate in HER2 Antibody Business (2019-2024)
Figure 52. Celltrion Revenue Growth Rate in HER2 Antibody Business (2019-2024)
Figure 53. Biocon Limited Revenue Growth Rate in HER2 Antibody Business (2019-2024)
Figure 54. Bio-Techne Revenue Growth Rate in HER2 Antibody Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies